Dr Agarwals Eye Hospital Limited
BSE: DRAGARWQ · Hospital
Snapshot
Unlock Dr Agarwals Eye Hospital Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Agarwal's Eye Hospital Ltd. is a specialised healthcare provider offering a comprehensive range of eye care solutions, including cataract, refractive, and retinal surgeries. Headquartered in Chennai, the company integrates clinical services with continuous training and research and development initiatives.
Business Model
The company generates revenue through the provision of specialised ophthalmic medical services, surgical procedures, and the sale of optical products. It operates through a network of hospitals that provide both routine eye care and advanced surgical interventions.
- Founded:1957
Growth Outlook
Growth is driven by the expansion of the hospital network and the increasing demand for advanced ophthalmic procedures such as LASIK and SMILE. Continued investment in research and development and clinical training programmes supports long-term service quality and market penetration.
Key Risks
- Regulatory Compliance. The company is subject to stringent healthcare regulations and licensing requirements that may impact operational costs and expansion plans.
- Competitive Intensity. The ophthalmic healthcare sector in India is highly fragmented, with significant competition from both large hospital chains and independent practitioners.
- Talent Retention. The quality of service is heavily dependent on the availability and retention of highly skilled ophthalmologists and specialised medical staff.
- Technological Obsolescence. Rapid advancements in surgical technology require continuous capital expenditure to maintain competitive standards of care.
Start your research today
Unlock AI insights, financials, peers and live data on Dr Agarwals Eye Hospital Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹497 Cr
TTM · standalone
NET PROFIT
₹76 Cr
TTM · standalone
EPS
₹158.78
TTM · standalone
RETURN ON EQUITY
27.4%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
18.9%
TTM · standalone
P/E
32.5×
Q1 FY27 · standalone
EV/EBITDA
16.3x
Q1 FY27 · standalone
EBITDA MARGIN
31.9%
TTM · standalone
NET PROFIT MARGIN
16.4%
Q1 FY27 · standalone
DEBT TO EQUITY
0.2x
Q1 FY27 · standalone
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Dr Agarwals Eye Hospital LimitedDRAGARWQ | ₹2,514 Cr | 32.5× | 16.34 | 20.0% | 31.9% | 27.4% | 18.9% | +3.9% |
Indraprastha Medical Corporation Ltd.INDRAMEDCO | ₹3,434 Cr | 16.5× | 11.29 | 10.9% | 19.9% | 28.1% | 34.6% | -25.7% |
K M C Speciality Hospitals (India) LimitedKMCSHIL | ₹2,645 Cr | 50.3× | 25.14 | 35.1% | 32.0% | 29.8% | 31.1% | +159.8% |
Shalby Ltd.SHALBY | ₹1,573 Cr | 38.2× | 12.30 | 6.5% | 14.5% | 3.8% | 7.8% | -49.4% |
Gujarat Kidney And Super Speciality LimitedGKSL | ₹1,401 Cr | — | — | — | 33.0% | — | — | — |
Gpt Healthcare Ltd.GPTHEALTH | ₹1,325 Cr | 26.3× | 13.73 | 18.1% | 19.8% | 18.3% | 20.0% | +2.6% |
As of Q1 FY27
Financials
Dr Agarwals Eye Hospital Limited
BSE: DRAGARWQ · Hospital
Snapshot
Unlock Dr Agarwals Eye Hospital Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dr. Agarwal's Eye Hospital Ltd. is a specialised healthcare provider offering a comprehensive range of eye care solutions, including cataract, refractive, and retinal surgeries. Headquartered in Chennai, the company integrates clinical services with continuous training and research and development initiatives.
Business Model
The company generates revenue through the provision of specialised ophthalmic medical services, surgical procedures, and the sale of optical products. It operates through a network of hospitals that provide both routine eye care and advanced surgical interventions.
- Founded:1957
Growth Outlook
Growth is driven by the expansion of the hospital network and the increasing demand for advanced ophthalmic procedures such as LASIK and SMILE. Continued investment in research and development and clinical training programmes supports long-term service quality and market penetration.
Key Risks
- Regulatory Compliance. The company is subject to stringent healthcare regulations and licensing requirements that may impact operational costs and expansion plans.
- Competitive Intensity. The ophthalmic healthcare sector in India is highly fragmented, with significant competition from both large hospital chains and independent practitioners.
- Talent Retention. The quality of service is heavily dependent on the availability and retention of highly skilled ophthalmologists and specialised medical staff.
- Technological Obsolescence. Rapid advancements in surgical technology require continuous capital expenditure to maintain competitive standards of care.
Start your research today
Unlock AI insights, financials, peers and live data on Dr Agarwals Eye Hospital Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹497 Cr
TTM · standalone
NET PROFIT
₹76 Cr
TTM · standalone
EPS
₹158.78
TTM · standalone
RETURN ON EQUITY
27.4%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
18.9%
TTM · standalone
P/E
32.5x
Q1 FY27 · standalone
EV/EBITDA
16.3x
Q1 FY27 · standalone
EBITDA MARGIN
31.9%
TTM · standalone
NET PROFIT MARGIN
16.4%
Q1 FY27 · standalone
DEBT TO EQUITY
0.2x
Q1 FY27 · standalone
Peers · Hospital
As of Q1 FY27